Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Paul S Calara, Jenny M Norlin, Rikard Althin, Katarina Steen Carlsson, Marcus Schmitt-Egenolf

Research output: Contribution to journalArticlepeer-review

Abstract

Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.
Original languageEnglish
JournalBioDrugs
Early online date2016 Feb 16
DOIs
Publication statusPublished - 2016

Subject classification (UKÄ)

  • Dermatology and Venereal Diseases

Fingerprint

Dive into the research topics of 'Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.'. Together they form a unique fingerprint.

Cite this